Atlas Trials

Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID

Clinical trial NCT02810444 · COMPLETED

Trial details

NCT number
NCT02810444
Sponsor
Biotest
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Immunodeficiency Disease
Start date
2016-10-04
Primary completion
2020-04-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.